amlodipine has been researched along with 1,4-dihydropyridine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Arrowsmith, JE; Blackburn, KJ; Burges, RA; Campbell, SF; Cross, PE; Gardiner, DG; Stubbs, JK | 1 |
| Vetrovec, GW | 1 |
| Fujiki, H; Hirano, T; Miyakoda, G; Mori, T; Ohura, M; Orito, K | 1 |
| Heath, B; Kass, RS; Xia, J | 1 |
| Birkenhäger, WH; Fagard, RH; Staessen, JA | 1 |
| Hirano, T; Kambe, T; Mori, T; Nakayama, N; Schwartz, A; Takase, H; Toide, K | 1 |
| Garcha, RS; Hughes, AD; Sever, PS | 1 |
| Bakris, GL; Epstein, M; Goldberg, R; Hung, E; Preston, R; Richardson, DJ; Smith, AC | 1 |
| Boatto, G; de Caprariis, P; Faedda, MV; Nieddu, M | 1 |
| Aizawa, Y; Atarashi, H; Fukatani, M; Hirai, M; Hirayama, A; Inoue, H; Kamakura, S; Kato, T; Kodama, I; Koretsune, Y; Kumagai, K; Kurachi, Y; Mitamura, H; Nakaya, H; Ogawa, S; Ohe, T; Ohtsu, H; Okumura, K; Saikawa, T; Sakurai, M; Sugi, K; Watanabe, E; Yamashita, T; Yamazaki, T | 1 |
| Ishibashi, T; Nishio, M; Yoshida, J | 1 |
| Ali, N; Palit, P | 1 |
| Furukawa, T; Kamegaya, E; Miyashita, Y; Nukada, T; Yoshii, M | 1 |
| Friis, S; Olsen, JH; Qian, L; Rhodes, SL; Ritz, B; Schernhammer, E | 1 |
| Aladejebi, O; Hockerman, GH; Lin, M | 1 |
| Bisenieks, E; Duburs, G; Gall Troselj, K; Krauze, A; Poikans, J; Velena, A; Zarkovic, N | 1 |
| Fendrikova, AV; Pyhalova, NE; Sirotenko, DV; Skibitsky, VV | 1 |
| Arima, H; Chaugai, S; Kerman, SRJ; Sepehry, AA; Sherpa, LY | 1 |
| Gao, S; Yan, N | 1 |
4 review(s) available for amlodipine and 1,4-dihydropyridine
| Article | Year |
|---|---|
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
Topics: Amlodipine; Calcium Channel Blockers; Diabetic Angiopathies; Dihydropyridines; Enalapril; Fosinopril; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Drug Synergism; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Myocardial Contraction; Nitric Oxide; Vasodilation; Vasodilator Agents | 2001 |
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.
Topics: Amlodipine; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cattle; Dihydropyridines; Epithelial Cells; Humans; Hydrogen; Lipoproteins, LDL; Mice; Microsomes; Mitochondria; Niacinamide; Nifedipine; Nitrobenzenes; Oxidants; Oxidative Stress; Piperazines | 2016 |
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
2 trial(s) available for amlodipine and 1,4-dihydropyridine
| Article | Year |
|---|---|
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Apoprotein(a); Benzazepines; Calcium Channel Blockers; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Lipoprotein(a); Male; Middle Aged; Pilot Projects; Triglycerides | 2002 |
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Secondary Prevention; Tetrazoles | 2006 |
13 other study(ies) available for amlodipine and 1,4-dihydropyridine
| Article | Year |
|---|---|
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
Topics: Amlodipine; Animals; Biological Assay; Biological Availability; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; Guinea Pigs; Hemodynamics; Kinetics; Male; Nifedipine; Pyridines; Rats; Vasoconstriction | 1986 |
Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
Topics: Amlodipine; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Electrophysiology; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Myocardial Contraction; Myocardial Ischemia; Ventricular Function, Left | 1994 |
Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Injections, Intravenous; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Venous Pressure | 1997 |
Molecular pharmacology of UK-118, 434-05, a permanently charged amlodipine analog.
Topics: Amlodipine; Binding Sites; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Gene Expression; Humans; Kidney; Membrane Potentials; Muscle, Smooth, Vascular; Myocardium; Structure-Activity Relationship | 1997 |
Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries.
Topics: Amlodipine; Angiotensin II; Arteries; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Flavonoids; Genistein; Humans; In Vitro Techniques; Nickel; Norepinephrine; Potassium; Ryanodine; Skin; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Enantiomeric separation by HPLC of 1,4-dihydropyridines with vancomycin as chiral selector.
Topics: Amlodipine; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dihydropyridines; Models, Molecular; Molecular Conformation; Stereoisomerism; Vancomycin | 2003 |
G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
Topics: Amlodipine; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinases; Dihydropyridines; G1 Phase; Humans; Nuclear Proteins; Phosphorylation; Repressor Proteins; Tumor Cells, Cultured | 2007 |
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis.
Topics: Administration, Oral; Amlodipine; Animals; Antiprotozoal Agents; Dihydropyridines; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Treatment Outcome | 2008 |
A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amlodipine; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Electrophysiology; Female; Lysine; Microelectrodes; Oocytes; Patch-Clamp Techniques; Xenopus | 2010 |
L-type calcium channel blockers and Parkinson disease in Denmark.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Community Health Planning; Denmark; Dihydropyridines; Female; Humans; Logistic Models; Male; Middle Aged; Outpatients; Parkinson Disease; Prescription Drugs; Registries; Retrospective Studies | 2010 |
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.
Topics: Amino Acid Sequence; Amlodipine; Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; HEK293 Cells; Humans; Molecular Sequence Data; Mutation; Nicardipine; Protein Conformation | 2011 |
[The Effectiveness of Combination Antihypertensive Therapy in Women With Hypothyroidism and the Metabolic Syndrome].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Hypothyroidism; Imidazoles; Losartan; Metabolic Syndrome; Middle Aged | 2016 |
Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Binding Sites; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cryoelectron Microscopy; Dihydropyridines; Molecular Dynamics Simulation; Nanostructures; Protein Structure, Tertiary; Stereoisomerism | 2021 |